By Reporter 吳典叡 / Comprehensive Report

[Link to Award Recipient List]

The US BIO International Convention is a major global event on the global biotechnology and pharmaceutical sector calendar, bringing together top pharmaceutical companies, biotech startups, and investors from around the world. The convention offers extensive opportunities for business collaboration, particularly in licensing, technology transfer,...

Pharmasaga officially initiated its Phase I clinical trial in December 2023, following dual approval from the Taiwan Food and Drug Administration (TFDA) and the U.S. Food and Drug Administration (USFDA).

On October 18th, 2023, at the Demo Day hosted by Honsun Precision Industry Co., Ltd. and H. Spectrum+, Pharmasaga, represented by CEO Ivan Chen, stood out from 183 submissions. The Company was selected as a strategic partner for Honsun Precision's expansion into the pharmaceutical sector.

!!! HAPPENING TODAY !!! The grandest biotech exhibition in Asia, BIO Asia 2022, has officially commenced on July 28th! We have already welcomed many distinguished guests to Pharmasaga's booth.

The Ministry of Science and Technology (MoST) led 14 top-tier Taiwanese biomedical startups to the BIO International Convention (US BIO), held in San Diego, USA, from June 13th to 16th. On the 15th, the MoST's Department of Industry-Academia Collaboration hosted a local Smart Health Demo Day to facilitate networking and matching...

Health Medical News/Reporter 林怡亭, Friday, June 10, 2022, 9:00 AM

By Keoni Everington, Taiwan News, Staff Writer2021/09/23 18:33

Diabetes has remained incurable for two millennia, primarily because patients lose the number and function of their pancreatic beta-cells during the disease progression. Consequently, diabetic patients are often forced to rely on insulin injections for survival.